国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
雷贝拉唑联合莫沙必利治疗功能性消化不良41例
Curative Effect of Rabeprazole Combined with Mosapride on 41 Patients with Functional Dyspepsia
  
DOI:
中文关键词:  功能性消化不良  雷贝拉唑  莫沙必利
英文关键词:Functional dyspepsia  Rabeprazole  Mosapride
基金项目:
作者单位
汪敏捷 淳安县第二人民医院(浙江淳安 311719) 
摘要点击次数: 994
全文下载次数: 1224
中文摘要:
      摘 要 目的:观察雷贝拉唑联合莫沙必利治疗功能性消化不良(FD)的疗效。方法:80例FD患者随机分为观察组41例和对照组39例。两组患者均予莫沙必利胶囊5 mg,po tid(餐前30 min服用),连续服用8周。观察组在此础上加用雷贝拉唑钠肠溶胶囊10 mg,po qd,连续服用8周。随访观察6个月,比较两组临床疗效和不良反应。结果:治疗8周后,观察组疗效显著高于对照组(P<0.05)。观察组出现不良反应2例,对照组出现不良反应4例,症状均较轻,不影响治疗。随访观察6个月,观察组复发率明显低于对照组(P<0.05)。结论: 雷贝拉唑联合莫沙必利治疗FD,能持续缓解患者的临床症状,安全性好,复发率低。
英文摘要:
      ABSTRACT Objective:To observe the curative effect of rabeprazole combined with mosapride on 40 patients with functional dyspepsia(FD). Methods: 80 patients with FD were randomly divided into the observation group and controlled group. All the patients took mosapride capsule 5mg orally, 3 times a day, half an hour before meal for 8 weeks. The patients of the observation group got extra treatment by taking rabeprazole sodium enteric coated capsules 10mg orally once a day for 8 weeks. The clinic curative effect and adverse reaction were observed for 6 month. Results: 8 weeks after treatment, the curative effect of the observation group was better than that of the controlled group(P<0.05). 2 cases of adverse reaction were found in the controlled group, 1 was bellyache and the other was diarrhea; 4 cases were found in the observation group, 1 was rash and the other 3 were diarrhea. All of these symptoms were mild and did not influence treatment. The responders of the two groups were followed for 6 months. The recurrence rate of the observation group was significantly lower than that of the controlled group(P<0.05). Conclusion: Treating FD with rabeprazole combined with mosapride was safe and could relieve the symptom of the patient and reduce the recurrence rate.
查看全文  查看/发表评论  下载PDF阅读器
关闭